Lack of myeloid cell infiltration as an acquired resistance strategy to immunotherapy

BACKGROUND: Immunotherapy of cancer is successful but tumor regression often is incomplete and followed by escape. Understanding the mechanisms underlying this acquired resistance will aid the development of more effective treatments. METHODS: We exploited a mouse model where tumor-specific therapeu...

Descripción completa

Detalles Bibliográficos
Autores principales: Beyranvand Nejad, Elham, Labrie, Camilla, Abdulrahman, Ziena, van Elsas, Marit J, Rademaker, Eva, Kleinovink, Jan Willem, van der Sluis, Tetje C, van Duikeren, Suzanne, Teunisse, Amina F A.S, Jochemsen, Aart G, Oosting, Jan, de Miranda, Noel F C C, Van Hall, Thorbald, Arens, Ramon, van der Burg, Sjoerd H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Basic Tumor Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467529/
https://www.ncbi.nlm.nih.gov/pubmed/32873723
http://dx.doi.org/10.1136/jitc-2020-001326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467529/
https://www.ncbi.nlm.nih.gov/pubmed/32873723
http://dx.doi.org/10.1136/jitc-2020-001326

Ejemplares similares